We present a reply to the invited commentary by Jubouri and Abdelhaliem
published in response to our original article titled: Prevention
vs Cure: is BioGlue priming the optimal strategy against E-Vita Neo
graft oozing? The authors highlight key issues associated with the
E-Vita Open NEO aortic arch prosthesis, chiefly, the propensity for the
prosthesis to exhibit post-anastomotic oozing. We read with great
interest their commentary and concur that the issues highlighted therein
are significant and warrant discussion.